Parsons Capital Management Inc Relmada Therapeutics, Inc. Transaction History
Parsons Capital Management Inc
- $1.45 Billion
- Q1 2024
A detailed history of Parsons Capital Management Inc transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Parsons Capital Management Inc holds 973,520 shares of RLMD stock, worth $3.11 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
973,520
Previous 949,841
2.49%
Holding current value
$3.11 Million
Previous $3.93 Million
15.11%
% of portfolio
0.31%
Previous 0.28%
Shares
18 transactions
Others Institutions Holding RLMD
# of Institutions
101Shares Held
14.3MCall Options Held
82KPut Options Held
73.9K-
Vanguard Group Inc Valley Forge, PA1.26MShares$4.01 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.24MShares$3.96 Million0.19% of portfolio
-
Vestal Point Capital, LP New York, NY1.2MShares$3.83 Million0.46% of portfolio
-
Acadian Asset Management LLC Boston, MA1.18MShares$3.77 Million0.02% of portfolio
-
Opaleye Management Inc. Boston, MA759KShares$2.42 Million0.86% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $91.3M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...